C07D 207/09
Radicals substituted by nitrogen atoms, not forming part of a nitro radical
C07D207/09 (Radicals substituted by nitrogen atoms, not forming part of a nitro radical) appears on 748 US grants and 834 published applications in this corpus.
Search patents in C07D- Granted patents
- 748
- Published applications
- 834
- Assignees
- 458
- Inventors
- 2,677
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 7 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 10 | 0 |
| 1989 | 6 | 0 |
| 1990 | 6 | 0 |
| 1991 | 6 | 0 |
| 1992 | 11 | 0 |
| 1993 | 9 | 0 |
| 1994 | 13 | 0 |
| 1995 | 12 | 0 |
| 1996 | 14 | 0 |
| 1997 | 15 | 0 |
| 1998 | 14 | 0 |
| 1999 | 9 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 4 |
| 2002 | 13 | 18 |
| 2003 | 10 | 21 |
| 2004 | 15 | 36 |
| 2005 | 13 | 37 |
| 2006 | 19 | 29 |
| 2007 | 24 | 42 |
| 2008 | 21 | 37 |
| 2009 | 23 | 46 |
| 2010 | 27 | 43 |
| 2011 | 29 | 32 |
| 2012 | 24 | 39 |
| 2013 | 38 | 38 |
| 2014 | 43 | 38 |
| 2015 | 25 | 37 |
| 2016 | 35 | 40 |
| 2017 | 29 | 32 |
| 2018 | 24 | 29 |
| 2019 | 27 | 25 |
| 2020 | 14 | 34 |
| 2021 | 26 | 28 |
| 2022 | 18 | 26 |
| 2023 | 15 | 38 |
| 2024 | 21 | 31 |
| 2025 | 12 | 30 |
| 2026 | 16 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ionizable cationic lipid analog material and use thereof as drug delivery carrier29 Sep 2026US 12,746,288 B2Guangzhou Lide Biomedicine Technology Co., Ltd.
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Linker, antibody-drug conjugate including same and use thereof30 Jun 2026US 12,668,573 B2Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd
- Inhibitors for programmed cell necrosis and preparation method therefor and use thereof23 Jun 2026US 12,662,473 B2Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystal form of lipoprotein compound and preparation method therefor8 Oct 2026US 2026/0306449 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Preparation method for intermediate of auristatin derivative17 Sep 2026US 2026/0274793 A1Remegen Co., Ltd.
- Novel co-drug, co-administration, and sequential administration of bispecific rbp4/ttr ligand and c20-d3-retinol for elimination of mechanism-based ocular adverse effects in treating macular degeneration and ttr amyloidosis3 Sep 2026US 2026/0256818 A1Rensselaer Polytechnic Institute
- Deubiquitinase inhibitors and methods of use thereof3 Sep 2026US 2026/0258011 A1
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
Most cited
By later US patents
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Modified tripeptides100US 4,596,819 AWarner-Lambert Company · 1986
- Cyclic amine compounds and pharmaceutical use91US 5,100,901 AEisai Co., Ltd. · 1992
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996